Literature DB >> 23275

Role of the enterohepatic circulation in the elimination of phenytoin in the rat.

A M El-Hawari, G L Plaa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 23275

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  5 in total

1.  An experimental design strategy for quantitating complex pharmacokinetic models: enterohepatic circulation with time-varying gallbladder emptying as an example.

Authors:  Y M Wang; R H Reuning
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

2.  Disposition of [4-14C]mofebutazone in the rat.

Authors:  V M Bass; R I Mrongovius; K E Schulte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

3.  Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite.

Authors:  H Paul; A Illing; E S House
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

4.  Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.

Authors:  F Sarhan; J M Engasser; A M Batt; J Magdalou; G Siest
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

5.  Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling.

Authors:  Hirotaka Ando; Shigeru Izawa; Wataru Hori; Ippei Nakagawa
Journal:  Theor Biol Med Model       Date:  2008-08-08       Impact factor: 2.432
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.